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RUNNING HEAD: AMPK protects against hypoventilation and apnea  
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AT A GLANCE COMMENTARY 
Scientific Knowledge on the Subject: Ventilatory adjustments are critical to the body’s capacity to 
accommodate deficits in oxygen availability during sleep and ascent to altitude. During hypoxia 
increased afferent discharge from the carotid bodies to the brainstem delivers increased ventilatory drive, 
which restores oxygen supply and protects against apnea. The precise molecular mechanisms involved 
remain unclear. However, natural selection in high-altitude populations has acted on the gene for the α1 
catalytic subunit of the AMP-activated protein kinase (AMPK), which governs cell-autonomous 
adaptations during metabolic stress.  
What This Study Adds to the Field: We demonstrate for the first time that AMPK deficiency leads to 
respiratory depression during hypoxia, characterized by hypoventilation and apnea rather than 
hyperventilation. Moreover, consequent deficits in the drive to breathe during hypoxia arise at the level 
of the brainstem, even where carotid body afferent input is normal. This identifies AMPK as a potential 
new target for therapeutic interventions for sleep disordered breathing associated with metabolic 
syndrome-related disorders and ascent to altitude. 
This article has an online data supplement, which is accessible from this issue's table of content online 
at www.atsjournals.org  
Page 1 of 50  AJRCCM Articles in Press. Published on 15-December-2015 as 10.1164/rccm.201508-1667OC 
 Copyright © 2015 by the American Thoracic Society 
 1
Abstract  
 
Rationale: Modulation of breathing by hypoxia accommodates variations in oxygen demand and 
supply during, for example, sleep and ascent to altitude, yet the precise molecular mechanisms remain 
controversial. Among those genes influenced by natural selection in high-altitude populations is that for 
the AMP-activated protein kinase (AMPK) α1 catalytic subunit, which governs cell autonomous 
adaptations during metabolic stress. 
 
Objective: We investigated whether or not AMPK-α1 and/or AMPK-α2 are required for the hypoxic 
ventilatory response and the mechanism of ventilatory dysfunctions arising from AMPK deficiency.  
 
Methods: Experiments utilized plethysmography, electrophysiology, functional magnetic resonance 
imaging and immediate early gene (cfos) expression to assess the hypoxic ventilatory response of mice 
with conditional deletion of the AMPK-α1 and/or AMPK-α2 genes in catecholaminergic cells, which 
comprise the hypoxia-responsive respiratory network from carotid body to brainstem.  
 
Measurements and Main Results: AMPK-α1+α2 deletion virtually abolished the hypoxic 
ventilatory response, and ventilatory depression during hypoxia was exacerbated under anesthesia. 
Rather than hyperventilating, mice lacking AMPK-α1+α2 exhibited hypoventilation and apnea during 
hypoxia, the primary precipitant being loss of AMPK-α1 expression. However, the carotid bodies of 
AMPK knockouts remained exquisitely sensitive to hypoxia, contrary to the view that the hypoxic 
ventilatory response is solely determined by increased carotid body afferent input to the brainstem. 
Regardless, functional magnetic resonance imaging and cfos expression revealed reduced activation by 
hypoxia of well-defined dorsal and ventral brainstem nuclei. 
 
Conclusions: AMPK is required to coordinate the activation by hypoxia of brainstem respiratory 
networks and deficiencies in AMPK expression precipitate hypoventilation and apnea, even where 
carotid body afferent input is normal. 
 
 
Word count = 246 
 
Keywords: AMP-activated protein kinase; ventilation; apnoea; hypoxia; brainstem. 
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AMPK is central to the cell autonomous control of energy supply (1) and comprises a heterotrimer of 
catalytic α and regulatory β and γ subunits, which are ubiquitously expressed throughout eukaryotes. 
Under metabolic stresses, such as hypoxia, binding of AMP to one site on the γ subunit and AMP or 
ADP to another increases AMPK activity, respectively, by allosteric activation and by promoting 
increased phosphorylation at Thr172 of the α subunit by Liver kinase B1 (2, 3). Alternatively calcium-
calmodulin-dependent kinase kinase-β may activate AMPK in response to increases in cytoplasmic 
calcium (4). AMPK switches off anabolic and switches on catabolic pathways (1), thereby compensating 
for deficits in ATP supply via, for example, mitochondrial oxidative-phosphorylation. Regulated O2 
supply is key to the maintenance of oxidative phosphorylation and thus cellular energy status in 
mammals, not least because of the limited capacity for cellular O2 storage relative to the extensive 
reserves of other substrates. It was proposed, therefore, that natural selection may have employed AMPK 
to coordinate whole-body adjustments in response to O2 deficits in animals (5). Consistent with this 
view, recent studies on high-altitude, Andean populations show that the gene for the AMPK-α1 subunit 
(PRKAA1) has been influenced by natural selection through single nucleotide polymorphisms (6). 
Moreover tissue-specific changes in AMPK expression occur in metabolic syndrome-related disorders 
that are associated with sleep-disordered breathing (7, 8).   
Ventilatory adjustments are critical to the body’s capacity to accommodate variations in O2 demand and 
supply during sleep and ascent to altitude, and this is exemplified by the fact that adaptation of mammals 
to hypoxia at altitude is initially characterized by progressive increases in ventilatory drive that partially 
restore arterial pO2 and protect against apnea (9). Ventilatory movements are delivered by respiratory 
central pattern generators (rCPGs) distributed bilaterally in the pons and ventral medulla. These semi-
autonomous neural networks comprise core circuits of excitatory and inhibitory interneurons that deliver 
rhythmic patterns of activity (10), and confer a set-point about which respiratory rhythm is continuously 
modulated through the integration of inputs from those central (10, 11) and peripheral chemosensors (12) 
which monitor O2, CO2 and pH. It is generally accepted that the carotid bodies represent the primary 
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arterial chemoreceptors (12), and that the acute hypoxic ventilatory response (HVR) is delivered by 
increased afferent discharge from the carotid bodies to the rCPGs via, in great part, catecholaminergic 
networks within the caudal brainstem (13, 14). 
The present study demonstrates conclusively that AMPK deficiency attenuates the HVR and thus 
precipitates hypoventilation and apnea, by blocking the activation of hypoxia-responsive nuclei within 
the caudal brainstem (15, 16) even where carotid body afferent inputs are normal. We have previously 
reported some of these results in the form of an abstract (17). 
 
METHODS 
Experiments complied with the regulations of the United Kingdom Animals (Scientific Procedures) Act 
of 1986.  
Breeding of mice, genotyping and single cell PCR 
Standard approaches were used (see Supplementary Methods in the online data supplement). All mice 
studied were between 3-12 months of age.  
Computational video analysis of thoracic activity 
Thoracic movements were captured by digital camera and the thoracic motion index calculated for each 
successive frame (see Supplementary Methods in the online data supplement). 
Isolated carotid body  
Methods for single fiber chemoafferent activity were adapted from those described previously (18); see 
Supplementary Methods in the online data supplement. Plots of firing frequency versus superfusate pO2 
were fitted by non-linear regression (GraphPad Prism).  
Plethysmography  
Following 10-20 min acclimation under normoxia (air) mice were exposed to hypoxia (12% or 8% O2, 
with 0.05% CO2, balanced with N2), or hypoxia+hypercapnia (8% O2, 5% CO2, balanced with N2).  
Apnea was defined as cessations of breathing greater than the average duration, including interval, of 2 
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successive breaths (500ms) during normoxia (19), with a detection threshold of 0.25 mmHg (SD of 
noise). Breathing variability was assessed by Poincaré plots and by calculating the SD of inter-breath 
(BB) intervals (19). 
Functional magnetic resonance imaging  
Mice were anaesthetized (0.8-1.3% isoflurane in air), body temperature maintained (37°C) and breathing 
frequency monitored by pressure pad sensor. A 7-T horizontal bore MRI scanner (Agilent Technologies, 
UK), equipped with a high-performance gradient insert (12cm inner diameter, maximum gradient 
strength 400mT/m) was used. A birdcage coil (72mm diameter) delivered radio frequency transmission, 
with signal reception via a mouse 2-channel phased array brain coil. All sequences were acquired with: 
field-of-view 19.2×19.2mm, 30 contiguous coronal slices of 0.4mm thickness. 
Structural images were acquired by fast spin echo sequence (train length 8): repetition time (TR) = 
3,100ms, effective echo time = 36ms, 8 signal averages, acquisition matrix 192x192, zero-filled to 
256x256. Functional images (230 volumes) were acquired during normoxia (21% O2) and hypoxia (8% 
O2) using 3-shot Echo Planar Imaging sequences: repetition time (TR) = 6,000ms (2,000ms per shot), 
effective echo time = 7.08ms; flip angle 90°, 1 signal average, acquisition matrix 64x64. 
Bias corrected (www.slicer.org) structural images were coregistered to a template (www.spmmouse.org) 
and averaged using SPM8 (Wellcome Trust Centre for Neuroimaging, UCL, UK). Functional data were 
realigned to mean volumes of each series, spatially normalized (SPM8 co-registration procedures) using 
each animal's structural scan, and smoothed by 0.7x0.7x4mm full width half maximum (FWHM) 
Gaussian filter.  
For first level analysis see Supplementary Methods in online data supplement. Second-level (group) 
analysis: The t-map for contrast (knockout>control) was thresholded at a level of P<0.005 with a 4 voxel 
cluster threshold (SPM8 imaging software; Wellcome Trust Centre for Neuroimaging, University 
College London, UK). Between-group differences were analyzed using a region of interest tool. For 
regions with significant group differences, all voxel signals were averaged at each time point (see also 
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Supplementary Methods in the online data supplement). 
cFos Labelling 
Mice were perfused following a single exposure to hypoxia (8% O2), brain sections incubated in anti-
cFos (rabbit; 1:20000 or 100000; Calbiochem) and anti-tyrosine hydroxylase (rat; 1:1000; Millipore) 
antibodies diluted in blocking buffer, then in biotinylated-anti-rabbit IgG (horse; 1:500; Vector 
Laboratories) and anti-rat IgG (goat ; 1:750; Invitogen, A594) secondary antibodies (see also 
Supplementary Methods in the online data supplement).  
Statistical analysis  
Statistical comparison was completed using GraphPad Prism 6 for the following: Afferent discharge, 
single or 2 factor ANOVA with Bonferroni Dunn post hoc analysis; Plethysmography, one-way 
ANOVA with Bonferroni multiple comparison’s test; P<0.05 was considered significant. For fMRI, a 
two-sample t-test (SPM8) was used with significance at P<0.005.   
 
RESULTS 
 
Loss of AMPK leads to ventilatory dysfunction during hypoxia  
Global knockout of both AMPK-α1 and -α2 is embryonic lethal. We therefore employed conditional 
deletion of AMPK-α1+α2 subunits, using mice in which these genes were flanked by loxP sequences 
(α1flx/α2flx (20)). To direct AMPK deletion to catecholaminergic cells of the carotid body (12) and 
brainstem (21) which contribute to ventilatory control during hypoxia, these were crossed with mice in 
which Cre recombinase was targeted via the tyrosine hydroxylase (TH) promoter (22). Transient 
developmental expression of TH occurs in disparate cell groups that do not express TH in the adult (22), 
including dorsal root ganglion cells, pancreatic islets, a subset of heart wall cells and a subset of 
gastrointestinal tract cells, none of which contribute to the acute HVR. Therefore, such conditional 
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AMPK deletion overcomes embryonic lethality and provides greater discrimination with respect to 
circuit mechanisms. Cell-specific gene deletion was confirmed by single-cell end-point RT-PCR and 
whole-brain qPCR (Figure 1A,B), and restriction of Cre to TH-positive cells in the adult mouse by viral 
transfection of a Cre-inducible vector carrying a reporter gene (see Figure E1 in the online data 
supplement).  
Under normoxia we found no significant difference between AMPK-α1+α2 knockouts and controls with 
respect to arterial spO2 (see Figure E2 in the online data supplement), venous blood gases, venous blood 
pH (see Table E1 in the online data supplement), weight-gain versus age (see Figure E3 in the online 
data supplement), breathing frequency, tidal volume or minute ventilation (see Figure E4 in the online 
data supplement). Nevertheless AMPK deletion profoundly affected the HVR. 
In control mice hypoxia evoked pronounced hyperventilation, characterized by robust increases in 
minute ventilation (Figure 1C,D), breathing frequency and tidal volume (see Figure E5 in the online 
data supplement). Dual deletion of AMPK-α1+α2 markedly attenuated the HVR in response to 12% 
(mild hypoxia, Figure 1C) and 8% O2 (severe hypoxia, Figure 1C), which conferred comparable stimuli 
in knockouts and controls in terms of the fall in arterial spO2 (see Figure E2 in the online data 
supplement). Surprisingly, the degree to which the HVR was attenuated increased in a manner directly 
related to the severity of hypoxia (Figure 1C,D), suggesting that AMPK offsets respiratory depression 
during hypoxia. 
Depression of the HVR was most severe upon exposure of AMPK-α1+α2 knockouts to 8% O2, which 
highlights the contribution of AMPK to all phases of the response. For controls, the initial “Augmenting 
Phase”, which is generally accepted to result from increased afferent input from the carotid body, peaked 
at 106±10% (~30s) relative to normoxia. Following subsequent ventilatory depression (roll off, ~100s) 
minute ventilation declined to 72±8% above that measured during normoxia, which was maintained for 
the latter 2-5min of hypoxia (Sustained Phase). For AMPK-α1+α2 knockouts minute ventilation during 
the HVR was markedly attenuated compared to controls, measuring, relative to normoxia, only 36±5% 
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(P<0.0001) during the Augmenting Phase before declining to -4±5% during the Sustained Phase 
(P<0.0001; 2-5min; 8% O2); deficits in minute ventilation resulted from reductions in both breathing 
frequency and tidal volume (see Figure E5 in the online data supplement). By contrast marked and 
comparable increases in minute ventilation were evoked upon exposure of controls and knockouts to 
hypoxia with hypercapnia (8% O2 + 5% CO2; Figure 1C). Moreover analysis of inter-breath intervals 
identified greater levels of disordered breathing in AMPK knockouts during hypoxia, but not 
hypercapnic hypoxia, and the severity of disordered breathing increased in a manner directly related to 
the degree of hypoxia (Figure 1D-G).  
Hypoxia-evoked hypoventilation in AMPK-α1+α2 knockouts was accompanied by frequent, prolonged 
apneas (≤6s; Figure 2 A,B; see also Movie E1-E2 in the online data supplement). Both spontaneous and 
post-sigh apneas were observed in AMPK-α1+α2 knockouts (Figure 2B) and these resulted from failure 
of ventilatory drive, which was evident from the absence within ventilatory records of transitions 
between inspiration and expiration (Personal communication BUXCO/DSI) and confirmed by 
computational video-analysis of thoracic activity (Figure 2C; see also Movie E1-E2 in the online data 
supplement). At 8% O2 apnea frequency measured 14.3±2.2min-1, apnea duration 953±40ms and apnea 
duration index (frequency x duration) 13.8±2.2, which were significantly greater (P<0.0001) than 
measures of apnea frequency (1.8±0.3min-1), apnea duration (709±17ms) and apnea duration index 
(1.3±0.2) during hyperventilation of controls (Figure 2DI-III). As might be expected given outcomes 
for minute ventilation, apnea frequency and duration also increased in a manner directly related to the 
severity of hypoxia and these increases were completely reversed during hypercapnic hypoxia (Figure 
2D). Therefore, AMPK deletion selectively blocks the HVR and thus precipitates hypoventilation and 
apnea. Furthermore, because hypercapnic ventilatory drive is retained in these mice and is delivered by 
CO2/pH sensitive catecholaminergic neurons (14, 23), it is evident that AMPK deletion does not simply 
block neuronal activation or synaptic transmission per se (also see below).  
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AMPK is not required for carotid body activation by hypoxia  
Surprisingly, reductions in superfusate pO2 raised chemoafferent discharge exponentially in all carotid 
bodies (Figure 3A,B), with peak discharge frequency at a pO2 of ~74 mmHg measuring 12.5±1.6Hz 
(n=10) for controls and 13.9±1.5Hz (n=8; P<0.001) for AMPK-α1+α2 knockouts. Therefore, AMPK is 
not required for carotid body activation during hypoxia and AMPK deletion does not compromise either 
exocytosis in or subsequent synaptic transmission by TH-expressing cells. Hence AMPK deletion must 
block the HVR by attenuating activation of the hypoxia-responsive respiratory network at a point distal 
to the carotid body. 
 
AMPK deletion markedly attenuates activation of brainstem nuclei by hypoxia  
Catecholaminergic and other neurons of the nucleus tractus solitarius (NTS) and ventrolateral medulla 
receive inputs from the carotid body (21, 24, 25), are activated by CNS hypoxia and may independently 
regulate rCPGs in a manner dependent on continued basal (normoxic) afferent input from the carotid 
bodies (13, 16, 26). Brainstem activity during hypoxia was therefore assessed by functional magnetic 
resonance imaging (fMRI) in anaesthetized mice, in light of the fact that ≤9% O2 induces cerebral 
vasodilation sufficient to eliminate the BOLD signal driven, under normoxia, by increases in cerebral 
blood flow in response to sensory stimulation (27). This allowed analysis of regional differences in 
signal change resulting from reductions in O2-consumption (decreased BOLD signal) in AMPK-α1+α2 
knockouts, relative to controls, during acute exposure to 8% O2 (2 min; ~40% spO2). Second level 
(group) fMRI analysis during hypoxia identified significantly different BOLD signals in two well-
defined dorsal (DAR) and ventral (VAR) active regions of the caudal brainstem of all AMPK-α1+α2 
knockouts when compared to controls (Figure 4C,D). Signal change for the DAR measured -23.58±1.17 
in controls and -14.93±0.91 (P<0.01) in AMPK-α1+α2 knockouts (Figure 4E), and, 
respectively, -11.78±0.91 and -8.3±0.37 for the VAR (P<0.05). The DAR and VAR exhibited 
pronounced right-left asymmetry, although removing the 4-voxel cluster threshold revealed limited 
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evidence of right-side-dominant, bilateral symmetry for the VAR alone (see Figure E6 in the online data 
supplement). Hypoxia (8% O2) evoked concomitant increases in breathing frequency of +16.54±12.92 
breaths min-1 in controls (n = 5; Figure 4 A,B). By contrast all AMPK-α1+α2 knockouts exhibited 
concomitant decreases in breathing frequency of -59.80±1.75 breaths min-1 (n = 6, P<0.001; Figure 4 
A,B). Furthermore, anesthesia sufficient to lower breathing frequency of AMPK-α1+α2 knockouts 
below 90 breaths min-1 precipitated irreversible respiratory failure within 30s of hypoxia (n=4; excluded 
from fMRI analysis). Therefore, anesthesia exacerbates hypoxic respiratory depression in AMPK-α1+α2 
knockouts.  
The caudal location relative to Bregma of the DAR (Figure 4C) is consistent with that of the NTS, 
within which poorly defined subgroups of A2 catecholaminergic neurons receive carotid body afferent 
inputs (24) and are activated during hypoxia (16, 21). The location of the VAR aligns well with the 
C1/A1 catecholaminergic neurons of the ventrolateral medulla, which are activated during hypoxia via 
afferent inputs from both carotid bodies and the NTS (21, 28, 29). We therefore used immediate early 
gene expression (cfos), the only truly physiological approach available (13, 21), to identify the 
subpopulation(s) of cells within the brainstem of AMPK-α1+α2 knockouts that exhibit deficits in 
activity during hypoxia in-vivo. Cell counts revealed no deficit in TH-positive cells across any of the 
regions studied (not shown). Regardless, AMPK deletion selectively attenuated hypoxia-evoked (8% O2) 
increases in cfos expression in cells adjacent to the area postrema (SubP) and within the medial 
subnucleus (SolM; Figure 5A lefthand panel). The SubP of controls contained 1.09±0.56 TH-positive 
and cFos-positive cells/100µm2 and 0.79±0.21 cFos-positive and TH-negative cells/100µm2, which fell 
in AMPK-α1+α2 knockouts to, respectively, 0.27±0.1 cells/100µm2 (p<0.01) and 0.28±0.1 cells/100µm2 
(p<0.01; Figure 5B). In SolM, however, a reduction in cfos expression was only observed in TH-
negative cells, from 1.91±0.3 cells/100µm2 in controls to 1.16±0.27 cells/100µm2 (p<0.05) in AMPK-
α1+α2 double knockouts (Figure 5B).  By contrast, a small but significant increase in the number of 
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cFos positive cells was observed in TH-positive neurons within the SolC, ventral and ventrolateral A2 
regions (Figure 5B). Rostral to these A2 nuclei, a significant reduction in cfos expression was also 
observed in all dorsal C2 neurons (Figure 5A,B), from 6.75±0.62 to 5.4±0.44 TH-positive cells/100µm2 
(p<0.05) and from 0.78±0.20 to 0.23±0.1 TH-negative cells/100µm2 (p<0.05). 
Ventral A1 regions of AMPK-α1+α2 knockouts, proximal to the VAR identified by fMRI, exhibited 
selective reductions of cfos expression in TH-positive, but not TH-negative, cells, from 4.66±0.26 to 
3.88±0.23 cells/100µm2 (p<0.05, Figure 5A,B). By contrast, AMPK deletion increased the number cfos 
expressing, TH-positive cells within the C1 region after hypoxia, from 5.05±0.21 to 6.29±0.30 
cells/100µm2 (p<0.05, Figure 5A,B).  
These data suggest differential AMPK-dependency of the activation during hypoxia of dorsal and ventral 
brainstem nuclei known to contribute to the HVR. Although we can’t rule out the possibility of 
confounding developmental abnormalities associated with AMPK deletion, we observe no deficits in 
ventilatory function during normoxia or hypercapnic hypoxia, no obvious structural anomaly by fMRI 
and no deficit in TH-positive or TH-negative cell count within the brainstem of AMPK-α1+α2 double 
knockouts. 
 
Loss of AMPK-α1 subunit expression is the primary cause of ventilatory dysfunction during 
hypoxia  
Figure 6 compares exemplar Poincaré plots of inter-breath interval (BBn) versus subsequent inter-breath 
interval (BBn+1) during (AI) normoxia and (BI) hypoxia for controls and knockouts of AMPK-α2, 
AMPK-α1 and AMPK-α1+α2. During hypoxia, while inter-breath intervals of AMPK-α2 knockouts 
were similar to controls, breathing irregularities resulted from AMPK-α1 deletion and these increased in 
severity with deletion of AMPK-α1+α2. Confirmation was provided by comparison of the SD of inter-
breath intervals (Figure 6AII,BII), which increased from 167±24ms during hypoxia with AMPK-α1 
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deletion to 238±23ms with deletion of AMPK-α1+α2 (P<0.001). Likewise, comparison of apnea 
duration index (Figure 6C) and minute ventilation (Figure 6D) demonstrated that ventilatory 
dysfunction was primarily driven by loss of AMPK-α1, but was more severe for AMPK-α1+α2 deletion. 
Hence AMPK-α2 containing heterotrimers confer only marginal compensation for loss of AMPK-α1. 
 
DISCUSSION 
Deficiencies of AMPK expression precipitated ventilatory dysfunction during hypoxia, characterized by 
marked hypoventilation, rather than hyperventilation, and frequent, prolonged apneas. Upon hypoxia at 
altitude or during sleep, AMPK activation may therefore support hyperventilation and thus ‘protect’ 
against hypoxia-induced ventilatory instability (9), while AMPK deficiency may confer greater 
susceptibility to disordered breathing. That loss of AMPK-α1 was the primary precipitant is notable in 
this respect, given that natural selection in high-altitude (Andean) populations has led to single 
nucleotide polymorphisms in PRKAA1, the gene for AMPK-α1 (6).  
Against expectations, however, AMPK deletion failed to attenuate hypoxia-evoked afferent discharge 
from the carotid body. This is contrary to our previous pharmacological studies which suggested that 
AMPK activation by hypoxia might elicit type I cell exocytosis and increase afferent discharge (18), but 
is consistent with more recent investigations (30). Previous conflicting observations may have arisen due 
to off target effects of pharmacological tools, such as AICAR-mediated reductions in the adenylate pool 
and ATP (20, 31). Regardless, AMPK is clearly not necessary for carotid body activation by hypoxia. 
Given that AMPK deletion blocked the HVR, this may appear contrary to the view that increased afferent 
discharge from the carotid body to the brainstem determines the ventilatory response to a fall in arterial 
pO2 (12). However, evidence suggests that the HVR is determined by the coordinated action of the 
carotid body and a hypoxia-responsive circuit within the brainstem (26) comprising, in great part, TH-
expressing catecholaminergic cells (14, 15). 
Consistent with this view, fMRI analysis identified that AMPK deletion markedly attenuated activation 
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by hypoxia of dorsal and ventral nuclei of the caudal brainstem, even though carotid body afferent 
discharge was retained, and this was corroborated by analysis of cfos expression. The caudal location 
relative to Bregma of the dorsal active region is consistent with areas of the NTS that are activated by 
hypoxia and which represent the primary site of receipt of carotid body afferent input (13, 16, 24). Here 
AMPK deletion selectively attenuated cfos expression during hypoxia by mixed subpopulations of C2 
neurons and A2 neurons (SubP; SolM) within the medial subnucleus proximal to the midline and the 
area postrema, which are activated during hypoxia (21). A2 neurons of the NTS provide afferent input to 
and determine, together with the carotid body, activation by hypoxia of A1/C1 neurons within the 
ventrolateral medulla (21, 28), the position of which (28) aligns well with the ventral active region 
identified by fMRI analysis; by contrast projections of the NTS mostly avoid (28) the Bötzinger and pre-
Bötzinger complexes (32). AMPK deletion selectively reduced cfos expression by TH-positive A1 
neurons during hypoxia. This may be significant given that carotid body afferent input alone is sufficient 
to activate C1 neurons and thus elicits hypotension (29), which was likewise induced by hypoxia in 
AMPK knockouts and controls. Our findings therefore suggest that respiratory input from the carotid 
chemoreflex may be blocked by loss of AMPK function within a neuronal circuit spanning the C2/A2 
neurons of the NTS and the A1 neurons of the ventrolateral medulla, which opposes respiratory 
depression during hypoxia. This is consistent with optogenetic and pharmacological interventions at the 
NTS (16, 33), and the proposal that NTS neurons lie on the sensory side of the central respiratory 
network (34, 35). Observed right-left asymmetry of brainstem activation during hypoxia (Figure 4) may 
provide for specialization sufficient to prevent delays in respiratory responses to hypoxic stress, by 
limiting conflicting outputs from each side of the brain (36) as for cognitive performance (37). 
Furthermore and despite the fact that cell counts were not biased by considerations on right-left 
asymmetry of brainstem activation, observed changes in cfos expression suggest that AMPK deficiency 
attenuates the activation by hypoxia of a discrete subpopulation of respiratory neurons within the C2, A2 
and A1 nuclei; which may also explain, in part, the modest deficits in cfos expression of AMPK 
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knockouts relative to the ventilatory dysfunction observed. In this respect it is notable that C2 and A2 
neurons are both catecholaminergic and glutamatergic (34, 38), and that 6-10% of TH-positive C2, A2 
and A1 neurons also express neuronal nitric oxide synthase, which supports the HVR by synthesizing 
NO (39) and/or S-nitrosothiols (40), and in a manner that may be facilitated by AMPK (41). However 
further investigation will be required to determine how right-left asymmetry is orchestrated by AMPK 
and the complex interplay of those neurotransmitters deployed during hypoxia.   
AMPK deletion in catecholaminergic cells may simply lead to the failure of central integration and 
transduction of peripheral chemoafferent input and consequent failure of the HVR, due to the inability of 
affected neurons to respond appropriately to metabolic stress (42). However, given that carotid body 
afferent discharge remains exquisitely sensitive to a fall in pO2 and ventilatory responses to hypercapnia 
remain unaffected even during severe (8%) hypoxia, our data demonstrate that AMPK deletion does not 
compromise, per se, the capacity during hypoxia for activation of chemosensory catecholaminergic 
neurons, exocytosis nor effective delivery of increased respiratory drive. This is consistent with the 
observation that neuronal integrity during hypoxia may be preserved, in part, by AMPK-independent 
mechanisms (43) that maintain ATP supply by accelerating glycolysis and in a manner supported by 
mobilization of astrocyte glycogen stores (44). That said, we must also consider why: 1) The degree of 
block by AMPK deletion of the HVR increased in a manner directly related to the severity of hypoxia; 2) 
The HVR can be triggered by CNS hypoxia alone, providing there is continued receipt of basal 
(normoxic) afferent input from the carotid bodies (26); 3) Interference at any point within this circuit 
abolishes the HVR, e.g., carotid body resection (45) or AMPK deletion. We therefore hypothesize that 
AMPK signaling pathways support coincidence detection at a point of signal integration within and thus 
activation of a hypoxia-responsive circuit that encompasses C2/A2 neurons and ventrolateral A1 
neurons. We envisage that coincidence detection is delivered by the capacity for AMPK activation by 
increases in AM(D)P/ATP ratio (1) determined by “local hypoxic stress” within the NTS (decreased 
ATP supply), which is coupled with “applied metabolic stress” (increased ATP usage) and/or increased 
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cytoplasmic Ca2+ delivered via afferent input from the carotid bodies to the NTS and, in turn, to 
ventrolateral A1 neurons (Figure 7). Afferent input and brainstem hypoxia could thereby determine, 
each in part, the set-point about which AMPK and thus the brainstem respiratory network are activated 
during hypoxia. Thereafter, AMPK-dependent modulation of cellular metabolism (1), ion channels and 
thus neuronal firing frequency (46) and / or transmitter release (40, 41) may facilitate efferent output and 
thus deliver increased drive to breathe, in a manner that may be attenuated or augmented by appropriate 
regulation of AMPK expression. 
It is also noteworthy that AMPK knockout mice not only hypoventilate during hypoxia, but also lie down 
and appear to enter a “torpor-like” state from which they recover rapidly when returned to normoxia (see 
Movie E1-E2 in the online data supplement). These mice may therefore engage alternative strategies to 
reduce O2 consumption and maintain supply, perhaps by entering a hypometabolic state (47). This would 
explain the comparable arterial spO2 for controls and AMPK knockouts during hypoxia, despite the 
attenuated HVR of the latter. 
During anesthesia, loss of suprapontine (voluntary) control of ventilation (48) may have exacerbated 
hypoxic ventilatory depression in AMPK knockouts and perhaps revealed the true extent of deficiencies 
in brainstem respiratory drive during hypoxia, which in the extreme precipitated death by irreversible 
respiratory failure. Interestingly, such outcomes are consistent with the effect of anesthesia on patients 
suffering from sleep apnea (49). Moreover observed respiratory failure could be triggered by 
exacerbation of the Cushing reflex (13, 50), although this is only elicited under anesthesia by ischemic 
hypoxia (~1% O2) and is maintained or enhanced by hypercapnia (13, 50, 51). By contrast, hypoxic 
ventilatory depression was evident in conscious AMPK knockouts during mild and severe hypoxia, as 
were deficits in brainstem activity, and was reversed rather than exacerbated by hypercapnia. 
Furthermore and contrary to the marked increases in blood pressure associated with the Cushing reflex 
(13, 50), hypoxic ventilatory depression in AMPK knockouts was associated with a fall in blood pressure 
equivalent to controls (see Figure E7 in the online data supplement) and wild-type mice (52). 
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Notwithstanding these facts, hypoxia triggers increased blood pressure in both rats (53) and humans (54) 
and we cannot rule out the possibility that outcomes for blood pressure may reflect species-dependent 
variations allied to the Cushing reflex (50).  
We conclude that AMPK opposes central respiratory depression during hypoxia and resists 
hypoventilation and apnea by supporting increases in central respiratory drive, even where carotid body 
afferent input is normal. Consequently, AMPK deficiency precipitates ventilatory dysfunction during 
hypoxia. AMPK is therefore key to O2 and thus energy (ATP) supply to the body as a whole. Moreover 
modulation of AMPK activity or expression may afford new therapeutic strategies against 
hypoventilation and apnea associated, for example, with metabolic syndrome-related disorders and 
ascent to altitude (7-9).   
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FIGURE LEGENDS 
 
Figure 1. Conditional deletion of AMPK catalytic α-subunits in tyrosine hydroxylase expressing 
cells markedly attenuates the hypoxic ventilatory response. (A) Single cell end-point RT-PCR 
amplicons for tyrosine hydroxylase and the catalytic α1 and α2 subunits of AMPK from acutely isolated 
carotid body type I cells of wild type (WT CB1 cells) and AMPK-α1 and -α2 double knockout mice 
(AMPK Double KO CB1 cells). (B) q-RT-PCR assays of AMPK-α1 and -α2 subunit expression of 
mouse brain as a % of β-actin from mice wild type (WT) and AMPK-α1 and -α2 double knockout mice 
(n=3). (C), Upper panels show example records of minute ventilation (ml min-1 g-1) versus time during 
12% O2, 8% O2 and 8% O2 with 5% CO2 for AMPK-α1 and -α2 double floxed (AMPK Double FX, black, 
n = 31) and AMPK-α1 and -α2 double knockout mice (AMPK Double KO, red, n = 22). Lower panels, 
Bar charts show mean±SEM for increase in minute ventilation for the peak of the Augmenting Phase 
(A), after 100s of Roll Off (RO) and the plateau of the Sustained Phase (SP) of the response to hypoxia; 
****=p<0.0001. (D-F) show exemplar Poincaré plots of the inter-breath interval (BBn) versus 
subsequent interval (BBn+1) of AMPK-α1 and -α2 double floxed (AMPK Double FX, black), and 
AMPK-α1 and -α2 double knockout (AMPK Double KO, red) mice during: (D) Mild hypoxia (12% O2 + 
0.05% CO2); (E) Severe hypoxia (8% O2 + 0.05% CO2); (F) hypoxia with hypercapnia (8% O2 + 5% 
CO2). (G) Shows corresponding mean ± SEM for the standard deviation (SD) of BBn and BBn+1 for 
each genotype during 12% O2 (AMPK double FX, n = 31; AMPK double KO, n = 22), 8% O2 + 0.05% 
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CO2 (AMPK Double FX, n = 12; AMPK Double KO, n = 19) and 8% O2 + 5% CO2 (AMPK Double FX, 
n = 20; AMPK Double KO, n = 29); *** =P<0.001, **** = p < 0.0001. 
 
Figure 2. Deletion of AMPK precipitates hypoventilation and apnea. (A) Records of ventilatory 
activity obtained using whole body plethysmography from AMPK Double FX (n = 31) and AMPK 
Double KO (n = 22) mice during (I) normoxia (21% O2), (II) hypoxia (8% O2) and (III) hypoxia with 
hypercapnia (8% O2 + 5% CO2). (BI-II) Typical ventilatory records on an expanded time scale during 
hypoxia (8% O2). (CI-II), Computational video analysis of thoracic movement (upper panels) with 
corresponding ventilatory traces (lower panels). (D) mean±SEM for (I) apneic index (per minute), (II) 
apnea duration (s) and (III) apnea-duration index (frequency x duration); (AMPK Double FX, n = 31; 
AMPK Double KO, n = 22) *=p<0.05, **=p<0.01, *** =P<0.001, ****=p< 0.0001.  
 
Figure 3. AMPK deletion does not inhibit carotid body activation by hypoxia. Upper panels show 
extracellular recordings of single fiber chemoafferent discharge vs pO2 for (A) AMPK-α1 and -α2 double 
floxed (AMPK Double FX) and (B) AMPK-α1 and -α2 double knockouts (AMPK Double KO); inset, 
single fiber discriminations. Middle, frequency-time histograms. Lower, frequency-pO2 response curves.  
 
Figure 4. Functional magnetic resonance imaging demonstrates that AMPK deletion inhibits 
activation by hypoxia of dorsal and ventral regions of the brainstem. (A) Example records of 
frequency (breaths min-1) versus time during hypoxia (8% O2) for anaesthetized AMPK-α1 and -α2 
double floxed (AMPK Double FX, black, n = 6) and AMPK-α1 and -α2 double knockout mice (AMPK 
Double KO, red, n = 6). (B) Bar charts show mean±SEM for change in breathing frequency during 
hypoxia; **=p< 0.01. (C) Dorsal (DAR) and ventral (VAR) active regions of brainstem that exhibited 
significantly lower signal change (p<0.005) during hypoxia in AMPK Double KO when compared to 
Double FX control mice.  (D) Variability of signal time courses for DAR and VAR in blue for each 
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individual mouse (same mice as for A, lower panel) overlaid on mean signal for AMPK Double FX 
(black line) and AMPK Double KO (red line); AU = arbitrary units. (E) mean±SEM percentage signal 
changes for DAR and VAR during hypoxia (same mice as for A, lower panel). *=p< 0.05, **=p< 0.01. 
 
Figure 5. AMPK deletion attenuates cFOS expression in discrete areas of the NTS and 
ventrolateral medulla. (A) Immunostaining of a brainstem section derived from an AMPK-α1 and -α2 
double knockout mouse, shows cfos (green) and Tyrosine Hydroxylase (TH, red) staining in the A2 and 
C2 regions of the nucleus of the solitary tract, and the ventrolateral C1/A1 region. Abbreviations: AP, 
area postrema; SubP, SolC, SolM, SolIM, SolDL, SolV, SolVL: Sub Postrema, commissural, medial, 
intermediate, dorsolateral, ventral and ventrolateral regions of the nucleus of the solitary tract; CC, 
central canal; IV, fourth ventricle; X, dorsal motor nucleus of the vagus; XII, hypoglossal  nucleus. Scale 
bar  50 µm. (B) Bar charts show for each region in (A) the number of TH-positive and TH-negative cells 
per 1000 µm2 in which cfos expression increased during hypoxia (8%O2) for AMPK-α1 and -α2 double 
floxed (AMPK Double FX, black, n = 19 sections, n = 6 mice) and AMPK-α1 and -α2 double knockout 
mice (AMPK Double KO, red, n = 17 sections, n = 6 mice). *=p< 0.01.  
 
Figure 6. Respiratory dysfunction during hypoxia is primarily mediated by loss of the AMPK-α1 
subunit.  Exemplar Poincaré plots of the inter-breath interval (BBn) versus subsequent interval (BBn+1) 
for mice with AMPK-α1 and -α2 floxed (AMPK Double FX, n=31), AMPK-α2 knockout (AMPK-α2 KO, 
n=16), AMPK-α1 knockout (AMPK-α1 KO, n=19), and AMPK-α1 and -α2 double knockout (AMPK 
Double KO, n=22) during: (AI) normoxia (21% O2); (BII) hypoxia (8% O2). (AII-BII) Corresponding 
mean±SEM for the standard deviation (SD) of BBn and BBn+1 for each genotype under normoxia and 8% 
O2. (C) mean±SEM for (I) apnoeic index (per minute), (II) apnea duration (s) and (III) apnea-duration 
index. (D) Increases in minute ventilation relative to normoxia at Augmenting Phase (A), after 100s of 
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Roll Off (RO) and the plateau of the Sustained Phase (SP) of the response to hypoxia; *=p<0.05, 
**=p<0.01, *** =P<0.001, ****=p< 0.0001. 
 
Figure 7. Schematic describes the new hypothesis on the integration by AMPK of local and applied 
metabolic stresses.  
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61x25mm (600 x 600 DPI)  
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Figure 4. Functional magnetic resonance imaging demonstrates that AMPK deletion inhibits activation by 
hypoxia of dorsal and ventral regions of the brainstem. (A) Example records of frequency (breaths min-1) 
versus time during hypoxia (8% O2) for anaesthetized AMPK-α1 and -α2 double floxed (AMPK Double FX, 
black, n = 6) and AMPK-α1 and -α2 double knockout mice (AMPK Double KO, red, n = 6). (B) Bar charts 
show mean±SEM for change in breathing frequency during hypoxia; **=p< 0.01. (C) Dorsal (DAR) and 
ventral (VAR) active regions of brainstem that exhibited significantly lower signal change (p<0.005) during 
hypoxia in AMPK Double KO when compared to Double FX control mice.  (D) Variability of signal time 
courses for DAR and VAR in blue for each individual mouse (same mice as for A, lower panel) overlaid on 
mean signal for AMPK Double FX (black line) and AMPK Double KO (red line); AU = arbitrary units. (E) 
mean±SEM percentage signal changes for DAR and VAR during hypoxia (same mice as for A, lower panel). 
*=p< 0.05, **=p< 0.01.  
2700x1587mm (72 x 72 DPI)  
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Figure 5. AMPK deletion attenuates cFOS expression in discrete areas of the NTS and ventrolateral medulla. 
(A) Immunostaining of a brainstem section derived from an AMPK-α1 and -α2 double knockout mouse, 
shows cfos (green) and Tyrosine Hydroxylase (TH, red) staining in the A2 and C2 regions of the nucleus of 
the solitary tract, and the ventrolateral C1/A1 region. Abbreviations: AP, area postrema; SubP, SolC, SolM, 
SolIM, SolDL, SolV, SolVL: Sub Postrema, commissural, medial, intermediate, dorsolateral, ventral and 
ventrolateral regions of the nucleus of the solitary tract; CC, central canal; IV, fourth ventricle; X, dorsal 
motor nucleus of the vagus; XII, hypoglossal  nucleus. Scale bar  50 µm. (B) Bar charts show for each 
region in (A) the number of TH-positive and TH-negative cells per 1000 µm2 in which cfos expression 
increased during hypoxia (8%O2) for AMPK-α1 and -α2 double floxed (AMPK Double FX, black, n = 19 
sections, n = 6 mice) and AMPK-α1 and -α2 double knockout mice (AMPK Double KO, red, n = 17 sections, n 
= 6 mice). *=p< 0.01.  
168x135mm (300 x 300 DPI)  
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SUPPLEMENTARY DATA 
Quantitative RT-PCR, Related to Figure 1B.  AMPK-α1 expression gave (mean±SEM) Ct = 26.8 ± 
0.05 (n = 3) for WT and Ct = 25.9 ± 0.02 (n = 3) for AMPK-α1 and -α2 double knockout mice; AMPK-
α2 expression gave Ct = 28.4 ± 0.004 (n = 3) for WT and Ct = 29.1 ± 0.03 (n = 3) for AMPK-α1 and -α2 
double knockout mice. β-actin expression gave Ct = 23.9 ± 0.03 (n = 3) for WT and Ct = 22.9 ± 0.02 (n 
= 3) for AMPK-α1 and -α2 double knockout mice 
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SUPPLEMENTARY METHODS 
 
Animal studies  
Experiments were performed in accordance with the regulations of the United Kingdom Animals 
(Scientific Procedures) Act of 1986. For statistical analysis, genotyping PCR, see Supplemental 
Methods. All studies and breeding were approved by the University of Edinburgh and performed under 
UK Home Office project licenses. 
 
Breeding of mice and genotyping  
We used conditional deletion of the genes for the AMPK-α1 and/or -α2 subunits, using mice in which the 
sequence encoding the catalytic site of either or both of the α subunits was flanked by loxP sequences 
(α1flx and α2flx; See Supplementary Reference (1)). To direct AMPK deletion to identified oxygen-
sensing cells of the carotid body and brainstem, these were crossed with mice in which Cre recombinase 
was under the control of the tyrosine hydroxylase (TH) promoter. We detected the presence of wild-type 
or floxed AMPK alleles and CRE recombinase by PCR. 15 µl samples were run on 2% agarose gels with 
10 µl SYBRSafe DNA Gel Stain (Invitrogen) in TBE buffer against a 100 bp DNA ladder 
(GeneRulerTM, Fermentas) using a Model 200/2.0 Power Supply (Bio-Rad). Gels were imaged using a 
Genius Bio Imaging System and GeneSnap software (Syngene). For tyrosine hydroxylase we used two 
primers: forward 5’ CACCCTGACCCAAGCACT 3’, reverse CTTTCCTTCCTTTATTGAGAT 3’, and 
for Cre we used one primer: 5’ GATACCTGGCCTGGTCTCG 3’ (Expected size WT=290bp, 
Cre=430bp). We used two primers for each AMPK catalytic subunit: α1-forward: 5’ 
TATTGCTGCCATTAGGCTAC 3’, α1-reverse: 5’ GACCTGACAGAATAGGATATGCCCAACCTC 
3’ (WT=588bp, Floxed=682bp); α2-forward 5’ GCTTAGCACGTTACCCTGGATGG 3’, α2-reverse: 5’ 
GTTATCAGCCCAACTAATTACAC 3’ (WT=204bp, Floxed=250bp). The PCR protocol used for all 
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genotype primers was: 92ºC for 5min, 92ºC for 45s, 56ºC for 45sec, 72ºC for 60s, and 72ºC for 7min for 
35 cycles and then 4ºC as the holding temperature. 
 
Single-cell end-point PCR  
Carotid bodies were incubated at 37°C for 25-30 min in isolation medium consisting of: 0.125mg/ml 
Trypsin (Sigma), 2.5mg/ml collagenase Type 1 (Worthington) made up in low Ca2+/low Mg2+ HBSS. 
During this incubation the carotid bodies were separated from the associated patch of artery. The carotid 
bodies were then transferred to low Ca2+/low Mg2+ HBSS containing trypsin inhibitor (0.5mg/ml) for 
5min at room temperature, and then to 2ml of pre-equilibrated (95% air, 5% CO2, 37°C) growth medium 
(F-12 Ham nutrient mix, 10% fetal bovine serum, 1% penicillin/streptomycin). The medium containing 
the carotid bodies was centrifuged and the pellet re-suspended in 100µl of growth medium. Carotid 
bodies were then disrupted by triturating using fire polished Pasteur pipettes. 
Amplification of cDNA isolated from different individual cells was run in parallel with negative and 
positive controls using an initial denaturing step at 94°C for 5min and then denaturing at 94°C for 30s, 
annealing at 60°C for 45s, and extension for 60s at 72°C with a final 7min extension at 72°C. Initially 15 
cycles were performed, followed by reaction and dilution for a further 38 cycles. To detect tyrosine 
hydroxylase, primers obtained from Qiagen (Quantitect Primer Assay, QT00101962) were used with an 
expected band length of 96bp. For the detection of AMPK two primers were used, forward and reverse, 
to generate an expected band length of 92bp. 
Negative controls included control cell aspirants, lacking reverse transcriptase, aspiration of extracellular 
medium and PCR controls; these produced no detectable amplicons, ruling out genomic or other 
contamination. 15µl samples and a 100bp DNA ladder (GeneRulerTM, Fermentas) were run on 2% 
agarose gels with SYBRSafe DNA Gel Stain (Invitrogen). Gels were imaged using a Genius Bio 
Imaging System and GeneSnap software (Syngene). Positive controls were from samples rich in 
adrenomedullary chromaffin cells, dissected from adrenal glands from C57/BL6 mice.  RNA was 
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extracted using the High Pure RNA Tissue Kit (Roche) following the manufacturer’s guidelines and the 
concentration determined using the Nanodrop 1000 spectrophotometer (ThermoScientific).  cDNA 
synthesis was carried out using the Transcriptor High Fidelity cDNA kit (Roche) following 
manufacturers instructions.  
 
Quantitative RT-PCR   
RNA from brain tissue was extracted using the High Pure RNA Tissue Kit (Roche) following the 
manufacturer’s guidelines and the concentration determined using the Nanodrop 1000 spectrophotometer 
(ThermoScientific).  cDNA synthesis was carried out using the Transcriptor High Fidelity cDNA 
synthesis Kit (Roche) following the manufacturers’ instructions. 
For qPCR analysis, 2.5 µl of cDNA in RNase free water was made up to 25 µl with FastStart Universal 
SYBR Green Master (ROX, 12.5 µl, Roche), Ultra Pure Water (8 µl, SIGMA) and fwd and rev primers 
for AMPK  α1 and α2. The sample was then centrifuged and 25 µl added to a MicroAmpTM Fast Optical 
96-Well Reaction Plate (Greiner bio-one), the reaction plate sealed with an optical adhesive cover 
(Applied Biosystems) and the plate centrifuged. The reaction was then run on a sequence detection 
system (Applied Biosystems) using AmpliTaq Fast DNA Polymerase, with a 2min initial step at 50oC, 
followed by a 10min step at 95oC, then a 15s step at 95oC which was repeated 40 times. Then a 
dissociation stage with a 15s step at 95oC followed by a 20s at 60oC and a 15s step at 95oC. Negative 
controls included control cell aspirants for which no reverse transcriptase was added, and aspiration of 
extracellular medium and PCR controls. None of the controls produced any detectable amplicon, ruling 
out genomic or other contamination.  
 
Viral injections of double-floxed reporter gene  
We made lateral injections adjacent to one of two readily identifiable clusters of catecholaminergic 
neurons, namely the locus coeruleus and nigrostriatal region. Injections proximal to the locus coeruleus 
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[anteroposterior (AP), 4.122 mm; mediolateral (ML), +/– 1.28 mm; dorsoventral (DV) 3.65 mm] were 
made through an internal cannula at a rate of 100 nl/min for 2.5 min (250nl total volume). After surgical 
procedures, animals were allowed to recover for at least one week. The mice were then perfused and 
brain extracted and sagittally sectioned (60µm thick) using a vibratome. For co-localization experiments, 
brain sections from eYFP-transduced mice were incubated in mouse anti-tyrosine hydroxylase (1:1000, 
Millipore, MAB-318). Sections were then incubated in goat anti-rabbit IgG secondary antibody (1:750, 
Invitogen, A594). 
 
Measurement of arterial oxygen saturation heart rate and blood pressure  
Arterial spO2 measurements and heart rate of mice were made by infrared using the 
MouseSTAT™ Pulse Oximeter (Kent Scientific, USA) and paw sensor (anesthetized) or Y-style tail 
sensor (conscious), with blood pressure recorded using a CODA STANDARD non-invasive blood 
pressure system (Kent Scientific, USA). 
 
Venous blood gas analysis  
Gas analysis (ABL90 Radiometer, Copenhagen) was performed on blood collected from the vena cava 
under terminal anaesthesia (Thiobutabarbital sodium, 120mg/kg IP).  Blood was drawn into a heparin-
coated syringe and analysis was performed within 1 minute of collection.  
 
Isolated carotid body  
Single fibre chemoafferent activity was amplified and filtered and recorded using a 1401 interface 
running Spike 2 software (Cambridge Electronic Design). Single- or few-fibre chemoafferent recordings 
were made from carotid bifurcations held in a small volume tissue bath, and superfused (36-37°C) with 
gassed (95% O2 and 5% CO2), bicarbonate-buffered saline solution (composition (mM): 125 NaCl, 3 
KCl, 1.25 NaH2PO4, 5 Na2SO4, 1.3 MgSO4, 24 NaHCO3, 2.4 CaCl2). Hypoxic gas tensions were 
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maintained and calibrated via a blood gas analyser.   
 
Plethysmography  
We used a Halcyon low noise pneumatochograph and FinePointe acquisition and analysis software 
(Buxco Research Systems, UK). Following 10-20 min of acclimation under normoxia mice were 
exposed to hypoxia (8% O2, with 0.05% CO2, balanced with N2), or hypoxia+hypercapnia (8% O2, 5% 
CO2, balanced with N2).  Throughout our analyses, we defined an apnea as a period of cessation of 
breathing that was greater than the average duration, including interval, of 2 successive breaths (~600 
ms) of control mice during normoxia. For these analyses we also utilized a threshold below which any 
event was considered to be within the signal noise (0.25 mmHg = standard deviation of noise). 
 
Computational analysis of thoracic movements  
Movements were captured using a digital camera synchronized with data acquisition via 
plethysmography. Within each frame of the movie we defined a region-of-interest (ROI) covering the 
side of the thorax of the mouse, low-pass filtered the MI at 10 Hz and calculated the motion index (MI) 
for each successive frame as:  
   
where cf,i is the grayscale level of the pixel i of the ROI in the frame f.  
 
Functional magnetic resonance imaging  
Six AMPK-α1flx and -α2flx and six AMPK-α1 and -α2 double knockout mice were imaged on a 7-T 
horizontal bore MRI scanner (Agilent Technologies, Yarnton, UK), equipped with a high-performance 
gradient insert (12-cm inner diameter, maximum gradient strength 400 mT/m). The mice were 
anesthetized with 0.8-1.3% isoflurane in air, placed in a cradle (Rapid Biomedical GmbH, Rimpar, 
Page 38 of 50 AJRCCM Articles in Press. Published on 15-December-2015 as 10.1164/rccm.201508-1667OC 
 Copyright © 2015 by the American Thoracic Society 
 17 
Germany), and the skull was fixed with plastic ear bars. Rectal temperature was monitored throughout 
the experiments, and body temperature was maintained at 37°C with a hot air fan. Respiration rate was 
monitored using a pressure pad sensor placed under the animal. A birdcage coil (72-mm diameter) was 
used for radio frequency transmission and a mouse 2-channel phased array brain coil for signal 
reception. All sequences were acquired with the following parameters: field-of-view 19.2 mm×19.2 mm, 
30 contiguous coronal slices of 0.4 mm thickness. Whole brain structural images were acquired using a 
fast spin echo sequence (echo train length 8) with the following parameters: repetition time (TR) = 
3,100ms, effective echo time = 36 ms; 8 signal averages, acquisition matrix 192 x 192, zero-filled to 
256x256. 
After this scan, functional image acquisition was started during which the concentration of the inhaled 
oxygen was altered: 5min normoxia (21% O2) was followed by two 2min periods of hypoxia (8% O2), 
with 7min of normoxia after each hypoxic period. Two hundred and thirty fMRI volumes were collected 
using a 3-shot Echo Planar Imaging sequence with the following parameters: effective repetition time 
(TR) = 6,000 ms (2,000ms per shot), effective echo time = 7.08 ms; flip angle 90°, 1 signal average, 
acquisition matrix 64 x 64. 
SPM8 (Wellcome Trust Centre for Neuroimaging, University College London, UK) was used for image 
analysis. Whole brain structural images were acquired using a fast spin echo sequence (echo train length 
8) with the following parameters: repetition time (TR) = 3,100ms, effective echo time = 36 ms; 8 signal 
averages, acquisition matrix 192 x 192, zero-filled to 256x256. Bias corrected (www.slicer.org) structural 
images were coregistered to a template (www.spmmouse.org) and averaged to create a study-specific 
structural template. Functional data of each animal was realigned to the mean volume in the series, and 
then spatially normalized according to SPM8 co-registration procedures using each individual animal's 
structural scan, and smoothed with a 0.7x0.7x4 mm full width half maximum (FWHM) Gaussian filter.  
First level statistical analysis (Figure E7) was performed using a general linear model implemented in 
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SPM8. The design matrix of the linear model incorporated a zero polynomial, estimated brain motion 
parameters, respiration rate signal and a predicted BOLD response which is obtained by convolving the 
boxcar of the block design with the SPM8 canonical hemodynamic response function. For each animal, a 
statistical parametric map of the t-statistic was generated for the (normoxia < hypoxia) signal 
contrast. Second-level (group) analysis and between-group differences were investigated using a two-
sample t-test in SPM8. The second level t-map for the contrast (knockout > control) was thresholded at a 
level of P<0.005 with a cluster threshold of 4 voxels (SPM8). A region of interest tool (http://
marsbar.sourceforge.net/) was used to analyze the nature of between-group differences.  For regions 
which showed significant group differences, the mean signal time series for each animal was computed 
by averaging all the voxel signals within each region at each time point. Finally, the percentage signal 
changes were calculated for each region and the group means compared.   
TH labeling and cFOS Expression 
Mice were deeply anesthetized and transcardially perfused 90 minutes after a single exposure to hypoxia 
(8% O2) and the 44 µM sections of the brainstem were cut by microtome. Alternate sections were 
collected together and processed by free-floating immunocytochemistry to detect FOS immunoreactivity 
and stain for TH positive cells. For cell counting see supplemental procedures. 
Brain sections were incubated overnight with shaking at 4oC in anti-FOS (polyclonal raised in rabbit, 
used at 1:10000, Calbiochem) and anti-tyrosine hydroxylase (raised in mouse; 1:1000, Millipore) 
antibodies diluted in blocking buffer. Sections were then incubated in biotinylated secondary anti-rabbit 
antibody raised in goat, 1:500 (Vector Labs) which served to amplify the FOS staining.  This was 
followed by incubation with secondary fluorescent conjugated antibodies (Alexa Fluor® 488-
streptavidin and Alexa Fluor ®568, 1:500 dilutions, Molecular Probes, Inc).  
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Two investigators independently quantified the number of FOS and TH positive cells in brainstem 
sections, blinded to the treatments at the time of counting. Images of the regions were acquired using a 
Leica digital camera, controlled by Leica acquisition software (AIS), and attached to an upright Leica 
microscope and x10 objective. Using ImageJ, these images were converted to 8 bit, thresholded using 
the same parameters, and TH- and FOS-positive cells counted using the Analyze Particles macro. The 
conditions for thresholding and for the macro were determined in part by comparing count results with 
manually counted images and ensuring that counts made manually and via the software matched for 20 
regions. Non-overlapping, multiple regions of interest (ROI) were used. The number of FOS-positive 
cells within each ROI were normalized by the surface area of that ROI to allow comparison.  
 
SUPPLEMENTARY REFERENCES 
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SUPPLEMENTARY FIGURES 
 
 
 
Figure E1. Cre expression in tyrosine hydroxylase expressing cells. Images of sagittal sections from 
the brain of a TH-Cre mouse after injection of AAV1/2 Cre-induced YFP virus into the locus coeruleus 
(LC) but not the nigrostriatal region (NST), left panels show immunostaining depicting tyrosine 
hydroxylase immunoreactivity (red) and right panels show Cre-induced YFP expression (green). Upper 
panels show 5x magnification, lower panels show 10x magnification.  
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Figure E2. Conditional deletion of AMPK catalytic α-subunits in tyrosine hydroxylase expressing 
cells markedly attenuates the hypoxic ventilatory response at similar levels of arterial O2 
saturation. (A) Bar charts show mean±SEM for the minute ventilation (ml min-1 g-1; upper panel) of 
AMPK-α1 and  -α2 floxed (AMPK Double FX, n=3) and AMPK- α1 and -α2 double knockout (AMPK 
Double KO, n=3) during the plateau (3-5min) of the Sustained Phase (SP) of the hypoxic ventilatory 
response. Lower panel shows mean±SEM for the apnoea-duration index (frequency x duration; n=3); 
*** = p < 0.001, **** = p < 0.0001. (B) Exemplar records from conscious (I) and anesthetized (II) 
AMPK Double FX (upper panel, black, n=3) and AMPK Double KO mice (middle panel, red, n=3) show 
the time course of changes in arterial oxygen saturation (spO2). Lower panels show bar charts of 
mean±SEM for arterial spO2 during normoxia, hypoxia (8% O2) and recovery during normoxia. 
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Figure E3. Body weight versus age of control and knockout mice. Values shown are mean±s.e.m. for 
body weight (g) versus age from 2 months to 12 months in 2 month intervals in the AMPK-α1 and -α2 
double floxed (AMPK Double FX), AMPK-α1 knockout (AMPK-α1 KO), AMPK-α2 knockout (AMPK-
α2 KO) and AMPK-α1 and -α2 double knockout (AMPK DKO) mice. 
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Figure E4. Breathing frequency, tidal volume and minute ventilation of experimental mice during 
normoxia. Scatter plots show individual points and mean±SEM for breathing frequency (min-1, upper 
panel) tidal volume (ml g-1, middle panel) and minute ventilation (ml min-1 g-1, lower panel) under 
normoxia for AMPK-α1 and -α2 double floxed (black, n = 31), AMPK-α1 knockout (AMPK-α1 KO, 
blue, n=19), AMPK-α2 knockout (AMPK-α2 KO, mauve, n=16), AMPK-α1 and -α2 double knockout 
mice (AMPK DKO, red, n = 22). 
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Figure E5. Effect of AMPK deletion on breathing frequency, tidal volume and minute ventilation 
during hypoxia. Upper panels show example records of minute ventilation (ml min-1 g-1) versus time 
during 12% O2 (D) 8% O2 and (E) 8% O2 with 5% CO2 for AMPK-α1 and -α2 double floxed (AMPK 
Double FX, black, n = 31) and AMPK-α1 and -α2 double knockout mice (AMPK Double KO, red, n = 
22). Lower panels, Bar charts show mean±s.e.m. for increase in minute ventilation for the peak of the 
Augmenting Phase (A), after 100s of Roll Off (RO) and the plateau of the Sustained Phase (SP) of the 
response to hypoxia; ****=p< 0.0001.  
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Figure E6. First and second level fMRI analysis. First level statistical analysis, changes in BOLD 
signal level during hypoxia (versus normoxia) were mapped for each animal; note, almost the entire 
brain shows highly significant signal reduction for both: (A) the six Double-KO; (B) the six Double-FX 
mice; (C) Second level of analysis, a two-sample t-test was performed to compare the BOLD responses 
of Double-KO and Double-FX during hypoxia. We thus identified brainstem regions demonstrating a 
reduced response in the Double-KO group versus the Double-FX group, which are overlaid on the study-
specific brain template with a statistical threshold of p<0.005 (t = 3.2). Colour scale indicates t-score.  
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Figure E7. Blood pressure and heart rate during normoxia and hypoxia. Data show for control and 
AMPK-α1 and -α2 double knockout (AMPK Double KO) mice: (A) Time course for changes in blood 
pressure during hypoxia (8% O2). (B) Time course for changes in heart rate during hypoxia (8% O2). (C) 
Mean±s.e.m. for systolic blood pressure, diastolic blood pressure, mean arterial blood pressure (MAP) 
and heart rat (HR) during normoxia, hypoxia and recovery. (n=3).  
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Table E1. Blood gases and pH 
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SUPPLEMENTARY MOVIES 
 
Movie E1. Exposure of an AMPK-α1 and -α2 double floxed (AMPK Double FLX) mouse to hypoxia 
(8% O2). 
 
Movie E2. Exposure of an AMPK-α1 and -α2 double knockout (AMPK Double KO) mouse to hypoxia 
(8% O2). 
 
 
  
Page 50 of 50 AJRCCM Articles in Press. Published on 15-December-2015 as 10.1164/rccm.201508-1667OC 
 Copyright © 2015 by the American Thoracic Society 
